Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
West Red Lake Gold Intersects 25.12 g/t Au over 5.5m, 39.46 g/t Au over 2m and 18.60 g/t Au over 4m at South Austin Zone – Madsen Mine
-
Mirasol Video Update on Sobek Copper-Gold Project – Highlighting the Recent Strategic Addition of Adjacent Rosita Property in Vicuña District, Chile
-
AIP Realty Trust Update on Strategic Review & Engagement of Raymond James
-
United Food and Commercial Workers Canada releases 2023 Annual Report
-
Condor Initiates Gas Field Production Enhancement Operations in the Republic of Uzbekistan
-
Kaixin Auto Holdings Announces Myanmar Order of 1,000 EVs
-
ECARX's Global Expansion Driven by Strong R&D and International Accreditations
-
Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
-
Puma Announces a Creative Deal to Unlock Value of its Assets in New Brunswick
-
Excitement Builds: Aqua-Tots Swim School Now Open in Holland, MI
-
EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer
-
Notice of Inducement Grants for Kurt Hoff, Lantronix Vice President, Worldwide Sales
-
WalkMe to Present at Upcoming Investor Conference
-
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PG
-
Blackwells Capital Releases Investor Presentation to its Fellow Disney Shareholders
-
Tecnoglass to Attend the Raymond James 45th Annual Institutional Investors Conference
-
Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer
-
PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-ED
-
Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller
-
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins
-
Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors
-
Verizon Innovative Learning reaches 7 million students nationwide to tackle digital divide
-
MAPLEBEAR INC. (NASDAQ: CART) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Maplebear Inc. d/b/a
-
XPONENTIAL FITNESS, INC. (NYSE: XPOF) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Xponential F
-
Velcan Holdings: Share buyback program - weekly statement
-
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
-
ECARX's Global Expansion Driven by Strong R&D and International Accreditations
-
Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometabolism-targeting pipeline into clinical development
-
Ferrari N.V.: Periodic Report on the Buyback Program
-
Probe Gold Announces Acquisition of the Beaufor and McKenzie Break Properties in Val-d’Or, Quebec
-
Monarch Sells Mining Assets to Probe Gold and Bullrun
-
Madison Metals Returns 2.78% U3O8 Over 4 Metres From Trench Sampling at Khan Project in Namibia, Africa
-
iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
-
TC Energy announces sale of Portland Natural Gas Transmission System
-
Healthcare Realty Trust Announces Planned Retirement of Two Directors and 2024 Nominees
-
Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
-
SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN
-
Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Bridger Aerospace Announces Fleet Deployment to Support Texas Firefighting Efforts
-
Kraken Robotics Signs Cooperative Research & Development Agreement with US Navy for next Generation Synthetic Aperture Sonar (SAS) Beamforming
-
Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
-
-
Net Asset Value(s)
-
Parsons Honored As One Of The World’s Most Ethical Companies For 15th Consecutive Year
-
Carlyle Secured Lending, Inc. Names Justin Plouffe CEO and Member of the Board of Directors
-
Archrock Announces Credit Rating Upgrade from S&P Global Ratings
-
KE Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on March 14, 2024 Eastern Time
-
Freedom Holdings Corporate Update: Management Announces Glendale Securities, Inc. Received Notification That the FINRA Review of The Form 211 Application Has Been Completed
-
The Ensign Group Acquires Two Skilled Nursing Facilities in Colorado
-
The Ensign Group Acquires Skilled Nursing Facility in Kansas
